The Valley Desk

NCT00206102 · Interventional trial

A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder

Overall registry status Completed

Phase 4

Conditions Schizoaffective Disorder, Schizophrenia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov